Our CEO Osamu Iizuka had a presentation at the 11th Digital Pathology & AI Congress USA
Our CEO Osamu Iizuka took the stage at the 11th Digital Pathology & AI Congress USA, held on Thursday, June 5, 2025, in Philadelphia, USA.
The conference served as an international platform with the theme of cutting-edge technologies and practical applications in digital pathology and AI, and the latest case studies of AI implementation were presented from diagnostics and fundamental research to clinical applications and the pharmaceutical and biotech industries. With exhibits from more than 30 companies and over 300 digital pathology professionals in attendance, the event provided a great opportunity for networking and staying up to date on industry trends.
During his presentation, he shared Medmain’s mission, technological innovations, business efforts in Japan, as well as the future prospects for the U.S. market. This was his first time presenting at a conference in the U.S., and it garnered significant attention from many professionals in the field of digital pathology, making it an invaluable opportunity.
Through active engagement on the global stage, we will continue driving technological innovation and advancing its social implementation to address medical challenges worldwide.